Hoya Corp (HOCPF)
122.34
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Hoya Price to Book Value: 6.866 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 6.866 |
| May 06, 2024 | 6.866 |
| May 03, 2024 | 6.462 |
| May 02, 2024 | 6.462 |
| May 01, 2024 | 6.515 |
| April 30, 2024 | 6.462 |
| April 29, 2024 | 6.420 |
| April 26, 2024 | 6.252 |
| April 25, 2024 | 6.252 |
| April 24, 2024 | 6.252 |
| April 23, 2024 | 6.252 |
| April 22, 2024 | 6.341 |
| April 19, 2024 | 6.294 |
| April 18, 2024 | 6.294 |
| April 17, 2024 | 6.328 |
| April 16, 2024 | 6.224 |
| April 15, 2024 | 6.056 |
| April 12, 2024 | 6.084 |
| April 11, 2024 | 6.069 |
| April 10, 2024 | 6.193 |
| April 09, 2024 | 6.378 |
| April 08, 2024 | 6.743 |
| April 05, 2024 | 6.743 |
| April 04, 2024 | 6.743 |
| April 03, 2024 | 7.202 |
| Date | Value |
|---|---|
| April 02, 2024 | 7.202 |
| April 01, 2024 | 7.202 |
| March 28, 2024 | 7.202 |
| March 27, 2024 | 7.202 |
| March 26, 2024 | 7.162 |
| March 25, 2024 | 7.162 |
| March 22, 2024 | 7.162 |
| March 21, 2024 | 7.162 |
| March 20, 2024 | 7.162 |
| March 19, 2024 | 7.162 |
| March 18, 2024 | 7.162 |
| March 15, 2024 | 7.162 |
| March 14, 2024 | 7.162 |
| March 13, 2024 | 7.162 |
| March 12, 2024 | 7.162 |
| March 11, 2024 | 7.450 |
| March 08, 2024 | 7.429 |
| March 07, 2024 | 7.429 |
| March 06, 2024 | 6.993 |
| March 05, 2024 | 6.993 |
| March 04, 2024 | 6.993 |
| March 01, 2024 | 6.993 |
| February 29, 2024 | 6.993 |
| February 28, 2024 | 6.993 |
| February 27, 2024 | 6.993 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.571
Minimum
Jun 04 2019
9.976
Maximum
Sep 15 2021
6.517
Average
6.301
Median
Feb 09 2023
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.8601 |
| Nxera Pharma Co Ltd | 1.803 |
| PeptiDream Inc | 5.797 |
| Stemcell Holdings Inc | -- |
| Healios KK | 3.273 |
Price to Book Value Related Metrics
| PE Ratio | 36.31 |
| PS Ratio | 7.806 |
| Price to Free Cash Flow | 35.57 |
| Price | 122.34 |
| Earnings Yield | 2.75% |
| Market Cap | 42.88B |
| Operating PE Ratio | 14.32 |
| Normalized PE Ratio | 34.82 |